Dr. Bartley Joseph Gill, MD, PhD

Dr. Gill practices at Complete Dermatology in Sugarland, Texas.

Dr. Gill's NPI, 1346669066, was assigned on April 9, 2014. Dr. Gill graduated from Baylor College Of Medicine in 2014. Dr. Gill's Texas license number on file is BP10049454.

Dr. Gill's primary practice is Complete Dermatology, at 7616 Branford Pl, Sugarland, TX 77479 in Fort Bend County. The practice phone is (281) 857-6870.

Dr. Gill's primary practice is Complete Dermatology in Sugarland, Texas. The medical group on file is Complete Dermatology. Dmand AI also links Dr. Gill to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gill practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Gill's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gill is board certified in dermatology by the American Board of Dermatology. Dr. Gill has a license on file in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Gill treats.

CMS data shows 5,007 Medicare services from Dr. Gill across 21 procedure codes in 2024, for 633 Medicare patients. Medicare paid $187,325 for them. Every service was in an office.

CMS counts 633 Medicare patients who saw Dr. Gill in 2024. The largest group is 65 to 74, with 387 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gill's median patient age at 63, with 43% women.

In 2024, Dr. Gill wrote 1,805 Medicare Part D claims for 620 patients. 86% of them were for generic drugs. CMS names the drug for 1,659 of them, across 30 drugs with 11 or more claims each, at $1,218,405 in total drug cost. In 2023, CMS named 1,568 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gill for performance year 2024, reported individually. Dr. Gill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,763 procedures of removal of skin lesions by Dr. Gill, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Gill, published from 2013 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Adenocarcinoma, Adenocarcinoma of Lung and Cell Line, Tumor. Dr. Gill's most frequent co-authors are Jessica Lynn Boulavsky, MD, Sanjay Chabra, DO and Harry Dao, MD.

Dmand AI links Dr. Gill to 4 clinical trials. Conditions studied include Dermatitis, Atopic, Eczema and Psoriasis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Gill that name 5 trials.

CMS Open Payments shows 1,305 general payments to Dr. Gill from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $174,507. It also lists 17 research payments totaling $19,093 from 2020 to 2024, naming 5 clinical trials.

Dr. Gill graduated from Baylor College Of Medicine in 2014.

Dr. Gill is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.